Total Funding
64
73
Total FundingSeries A raised
Growth Score 64 in past quarter
-2 pts
Heat Score 73 in past quarter
10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
74824
Delivering RNA Therapeutics to Precise Target-Site Locations
- Annie Sabbah: CTO & Co-Founder
- Ronen Eavri: CEO & Co-Founder
About the Company
Providing a solution to one of the largest challenges in RNA therapeutics – selective delivery to target cells Exciting advancements in the biotech field are marking RNA therapies as promising candidates for the treatment of diseases that were considered untreatable thus far. However, the largest challenge in developing innovative RNA therapeutics
is protecting them from degradation and delivering these molecules to the selected target tissue or cell. Barcode is enabling RNA therapeutics and vaccines by developing and testing new delivery formulations.